Poststroke depression: A review

Canadian Journal of Psychiatry

Volumn 55, Issue 6, 2010, Pages 341-349

  Robinson, Robert G ^a   Spalletta, Gianfranco ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Diagnosis; Mechanism of depression; Mortality; Poststroke depression; Prevalence; Stroke related impairments

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; MIANSERIN; NORTRIPTYLINE; PLACEBO; REBOXETINE; SERTRALINE;

BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DATA BASE; DEPRESSION; DRUG DOSE INCREASE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MAJOR DEPRESSION; MEDLINE; MORTALITY; POSTSTROKE DEPRESSION; PREVALENCE; PUBLICATION; REVIEW; STROKE; CEREBRAL INFARCTION; CLASSIFICATION; COGNITION DISORDERS; CONTROLLED CLINICAL TRIAL (TOPIC); CROSS-SECTIONAL STUDY; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DISABILITY; DOUBLE BLIND PROCEDURE; PROGNOSIS; PSYCHOLOGY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ANTIDEPRESSIVE AGENTS; CEREBRAL INFARCTION; COGNITION DISORDERS; CONTROLLED CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; PROGNOSIS; TREATMENT OUTCOME;

EID: 77953742030     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371005500602     Document Type: Review

References (106)

1. Kraepelin E. Manic depressive insanity and paranoia. Edinburgh (GB): E & S Livingstone; 1921.
2. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). New York (NY): Biometric Research, New York State Psychiatric Institute; 1995.
3. Morris PLP, Robinson RG, Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. Intl J Psychiatr Med. 1990;20(4):349-364.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC):APA; 1994.
5. Spalletta G, Ripa A, Caltagirone C. Symptom profile of DSM-IV major and minor depressive disorders in first-ever stroke patients. Am J Geriatr Psychiatry. 2005;13(2):108-115.
6. Paradiso S, Ohkubo T, Robinson RG. Vegetative and psychological symptoms associated with depressed mood over the first two years after stroke. Int J Psychiatry Med. 1997;27(2):137-157.
7. Damecour CL, Caplan D. The relationship of depression to symptomatology and lesion site in aphasic patients. Cortex. 1991;27:385-401.
8. Carson AJ, MacHale S, Allen K, et al. Depression after stroke and lesion location: a systematic review. Lancet. 2000;356(9224):122-126.
9. Bhogal SK, Teasell R, Foley N, et al. Lesion location and poststroke depression. Systematic review of the methodological limitations in the literature. Stroke. 2004;35:794-802.
10. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients: a 3-year longitudinal study. Stroke. 1993;24(7):976-982.
11. Morris PLP, Robinson RG, Raphael B, et al. Lesion location and post-stroke depression. J Neuropsychiatry Clin Neurosci. 1996;8:399-403.
12. Robinson RG. The clinical neuropsychiatry of stroke. 2nd ed. Cambridge (MA): Cambridge University Press; 2006.
13. Robinson RG, Szetela B. Mood change following left hemispheric brain injury. Ann Neurol. 1981;9:447-453.
14. Eastwood MR, Rifat SL, Nobbs H, et al. Mood disorder following cerebrovascular accident. Br J Psychiatry. 1989;154:195-200.
15. Narushima K, Kosier JT, Robinson RG. A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci. 2003;15(4):422-430.
16. Sinyor D, Amato P, Kaloupek P. Post-stroke depression: relationship to functional impairment, coping strategies, and rehabilitation outcome. Stroke. 1986;17:112-117.
17. Parikh RM, Robinson RG, Lipsey JR, et al. The impact of poststroke depression on recovery in activities of daily living over two-year follow-up. Arch Neurol. 1990;47:785-789.
18. Pohjasvaara T, Vataja R, Leppavuori A, et al. Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol. 2001;8(4):315-319.
19. Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(10):2296-2301.
20. Narushima K, Robinson RG. The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression: is there a time-related therapeutic window? J Nerv Ment Dis. 2003;191(10):645-652.
21. Wells CE. Pseudodementia. Am J Psychiatry. 1979;136:895-900.
22. Robinson RG, Bolla-Wilson K, Kaplan E, et al. Depression influences intellectual impairment in stroke patients. Br J Psychiatry. 1986;148:541-547.
23. Starkstein SE, Robinson RG, Price TR. Comparison of patients with and without post-stroke major depression matched for size and location of lesion. Arch Gen Psychiatry. 1988;45:247-252.
24. Downhill JE Jr, Robinson RG. Longitudinal assessment of depression and cognitive impairment following stroke. J Nerv Ment Dis. 1994;182:425-431.
25. Spalletta G, Guida G, De Angelis D, et al. Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness. J Neurol. 2002;249(11):1541-1551.
26. Andersen G, Vestergaard K, Riis JO, et al. Intellectual impairment in the first year following stroke, compared to an age-matched population sample. Cerebrovasc Dis. 1996;6(6):363-369.
27. Kimura M, Robinson RG, Kosier T. Treatment of cognitive impairment after poststroke depression. Stroke. 2000;31(7):1482-1486.
28. Narushima K, Chan KL, Kosier JT, et al. Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression. Am J Psychiatry. 2003;160(6):1157-1162.
29. Morris PLP, Robinson RG, Samuels J. Depression, introversion and mortality following stroke. Aust N Z J Psychiatry. 1993;27(3):443-449.
30. House A, Knapp P, Bamford J, et al. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke. 2001;32(3):696-701.
31. Williams LS, Ghose SS, Swindle RW. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry. 2004;161(6):1090-1095.
32. Robinson RG, Spalletta G, Jorge RE, et al. Decreased heart rate variability is associated with poststroke depression. Am J Geriatr Psychiatry. 2008;16(11):867-873.
33. Tokgozoglu SL, Batur MK, Topcuoglu MA, et al. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke. 1999;30(7):1307-1311.
34. Makikallio AM, Makikallio TH, Korpelainen JT, et al. Heart rate dynamics predict poststroke mortality. Neurology. 2004;62(10):1822-1826.
35. Robinson RG, Kubos KL, Starr LB, et al. Mood disorders in stroke patients: importance of location of lesion. Brain. 1984;107(Pt 1):81-93.
36. Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of post-stroke mood disorders. Brain. 1987;110:1045-1059.
37. Astrom M, Olsson T, Asplund K. Different linkage of depression to hypercortisolism early versus late after stroke: a 3-year longitudinal study. Stroke. 1993;24:52-57.
38. Herrmann N, Black SE, Lawrence J, et al. The Sunnybrook stroke study. A prospective study of depressive symptoms and functional outcome. Stroke. 1998;29:618-624.
39. Morris PL, Robinson RG, de Carvalho ML, et al. Lesion characteristics and depressed mood in the stroke data bank study. J Neuropsychiatry Clin Neurosci. 1996;8:153-159.
40. Spalletta G, Bossu P, Ciaramella A, et al. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry. 2006;11(11):984-991.
41. O'Brien SM, Scott LV, Dinan TG. Antidepressant therapy and C-reactive protein levels. Br J Psychiatry. 2006;188:449-452.
42. Bossù P, Salani F, Cacciari C, et al. Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res. 2009;6(3):163-170.
43. Kohen R, Cain KC, Mitchell PH, et al. Association of serotonin transporter gene polymorphisms with poststroke depression. Arch Gen Psychiatry. 2008;65(11):1296-1302.
44. Lipsey JR, Robinson RG, Pearlson GD, et al. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet. 1984;1(8372):297-300.
45. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke. 1994;25:1099-1104.
46. Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry. 2000;157(3):351-359.
47. Jorge RE, Robinson RG, Arndt S, et al. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry. 2003;160(10):1823-1829.
48. Rampello L, Alvano A, Chiechio S, et al. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study. Arch Gerontol Geriatr. 2005;40(3):275-285.
49. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:551-571.
50. Murray GB, Shea V, Conn DK. Electroconvulsive therapy for poststroke depression. J Clin Psychiatry. 1986;47(5):258-260.
51. Lincoln NB, Nicholl CR, Flannaghan T, et al. The validity of questionnaire measures for assessing depression after stroke. Clin Rehabil. 2003;17(8):840-846.
52. Palomäki H, Kaste M, Berg A, et al. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mainserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry. 1999;66(4):490-494.
53. Almeida OP, Waterreus A, Hankey GJ. Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry. 2006;67(7):1104-1109.
54. Rasmussen A, Lunde M, Poulsen DL, et al. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics. 2003;44(3):216-221.
55. Robinson RG, Jorge RE, Moser DJ, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA. 2008;299(20):2391-2400.
56. Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke, a community study of its frequency. Br J Psychiatry. 1987;151:200-205. (Pubitemid 17102096)
57. House A, Dennis M, Mogridge L, et al. Mood disorders in the year after first stroke. Br J Psychiatry. 1991;158:83-92.
58. Burvill PW, Johnson GA, Jamrozik KD, et al. Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry. 1995;166(3):320-327.
59. Kotila M, Numminen H, Waltimo O, et al. Depression after stroke: results of the FINNSTROKE Study. Stroke. 1998;29:368-372. (Pubitemid 28086678)
60. Hayee MA, Akhtar N, Haque A, et al. Depression after stroke-analysis of 297 stroke patients. Bangladesh Med Res Counc Bull. 2001;27(3):96-102.
61. Stewart R, Prince M, Richards M, et al. Stroke, vascular risk factors and depression - cross-sectional study in a UK Caribbean-born population. Br J Psychiatry. 2001;178:23-28. (Pubitemid 32055641)
62. Desmond DW, Remien RH, Moroney JT, et al. Ischemic stroke and depression. J Int Neuropsychol Soc. 2003;9(3):429-439.
63. Ebrahim S, Barer D, Nouri F. Affective illness after stroke. Br J Psychiatry. 1987;151:52-56.
64. Shima S, Kitagawa Y, Kitamura T, et al. Poststroke depression. Gen Hosp Psychiatry. 1994;16(4):286-289.
65. Gonzalez-Torrecillas JL, Mendlewicz J, Lobo A. Effects of early treatment of poststroke depression on neuropsychological rehabilitation. Int Psychogeriatr. 1995;7(4):547-560. (Pubitemid 26105909)
66. Herrmann M, Bartles C, Wallesch CW. Depression in acute and chronic aphasia: symptoms, pathoanatomical-clinical correlations and functional implications. J Neurol Neurosurg Psychiatry. 1993;56:672-678. (Pubitemid 23203767)
67. Andersen G, Vestergaard K, Riis JO, et al. Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale. Acta Psychiatr Scand. 1994;90(8875):190-195. (Pubitemid 24291618)
68. Kauhanen M, Korpelainen JT, Hiltunen P, et al. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke. 1999;30(9):1875-1880. (Pubitemid 29411830)
69. Gainotti G, Azzoni A, Marra C. Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry. 1999;175:163-167. (Pubitemid 29359380)
70. Aben I, Verhey F, Lousberg R, et al. Validity of the Beck depression inventory, hospital anxiety and depression scale, SCL-90, and Hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics. 2002;43(5):386-393.
71. Singh A, Black SE, Herrmann N, et al. Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke. 2000;31:637-644. (Pubitemid 30131648)
72. Berg A, Palomäki H, Lehtihalmes M, et al. Poststroke depression: an 18-month follow-up. Stroke. 2003;34(1):138-143.
73. Folstein MF, Maiberger R, McHugh PR. Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry. 1977;40:1018-1020. (Pubitemid 8253479)
74. Finklestein S, Benowitz LI, Baldessarini RJ, et al. Mood, vegetative disturbance, and dexamethasone suppression test after stroke. Ann Neurol. 1982;12:463-468. (Pubitemid 12006882)
75. Finset A, Goffeng L, Landro NI, et al. Depressed mood and intra-hemispheric location of lesion in right hemisphere stroke patients. Scand J Rehabil Med. 1989;21:1-6. (Pubitemid 19077521)
76. Schubert DSP, Taylor C, Lee S, et al. Physical consequences of depression in the stroke patient. Gen Hosp Psychiatry. 1992;14:69-76.
77. Schwartz JA, Speed NM, Brunberg JA, et al. Depression in stroke rehabilitation. Biol Psychiatry. 1993;33:694-699.
78. Robinson RG. Stroke. In: Lauterbach EC, editor. Psychiatric management in neurological disease. Washington (DC): American Psychiatric Association; 2000. p 219-247.
79. Cassidy E, O'Connor R, O'Keane V. Prevalence of post-stroke depression in an Irish sample and its relationship with disability and outcome following inpatient rehabilitation. Disabil Rehabil. 2004;26(2):71-77. (Pubitemid 38181106)
80. Pohjasvaara T, Leppavuori A, Siira I, et al. Frequency and clinical determinants of poststroke depression. Stroke. 1998;29:2311-2317. (Pubitemid 28511949)
81. Feibel JH, Springer CJ. Depression and failure to resume social activities after stroke. Arch Phys Med Rehabil. 1982;63:276-278.
82. Robinson RG, Price TR. Post-stroke depressive disorders: a follow-up study of 103 outpatients. Stroke. 1982;13:635-641.
83. Kim JS, Choi-Kwon S. Poststroke depression and emotional incontinence: correlation with lesion location. Neurology. 2000;54(9):1805-1810. (Pubitemid 30428409)
84. Collin SJ, Tinson D, Lincoln NB. Depression after stroke. Clin Rehabil. 1987;1:27-32.
85. Castillo CS, Schultz SK, Robinson RG. Clinical correlates of early-onset and late-onset poststroke generalized anxiety. Am J Psychiatry. 1995;152:1174-1179.
86. Robinson RG, Starr LB, Kubos KL, et al. A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke. 1983;14:736-744.
87. Angeleri F, Angeleri VA, Foschi N, et al. The influence of depression, social activity, and family stress on functional outcome after stroke. Stroke. 1993;24(20):1478-1483. (Pubitemid 23285199)
88. Shima S. The efficacy of antidepressants in post-stroke depression. Keio J Med. 1997;46(1):25-26.
89. Ramasubbu R, Robinson RG, Flint AJ, et al. Functional impairment associated with acute poststroke depression: the Stroke Data Bank Study. J Neuropsychiatry Clin Neurosci. 1998;10(1):26-33. (Pubitemid 28135120)
90. Kauhanen ML, Korpelainen JT, Hiltunen P, et al. Domains and determinants of of life after stroke caused by brain infarction. Arch Phys Med Rehabil. 2000;81(12):1541-1546.
91. Gainotti G, Antonucci G, Marra C, et al. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry. 2001;71(2):258-261. (Pubitemid 32675158)
92. van de Weg FB, Kuik DJ, Lankhorst GJ. Post-stroke depression and functional outcome: a cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil. 1999;13:268-272. (Pubitemid 29271980)
93. Paolucci S, Antonucci G, Grasso MG, et al. Early versus delayed inpatient stroke rehabilitation: a matched comparison conducted in Italy. Arch Phys Med Rehabil. 2000;81(6):695-700. (Pubitemid 30349707)
94. Paolucci S, Antonucci G, Grasso MG, et al. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study. Cerebrovasc Dis. 2001;12(3):264-271.
95. Paolucci S, Antonucci G, Pratesi L, et al. Poststroke depression and its role in rehabilitation of inpatients. Arch Phys Med Rehabil. 1999;80:985-990. (Pubitemid 29439307)
96. Paolucci S, Grasso MG, Antonucci G, et al. One-year follow-up in stroke patients discharged from rehabilitation hospital. Cerebrovasc Dis. 2000;10(1):25-32. (Pubitemid 30034854)
97. Sturm JW, Donnan GA, Dewey HM, et al. Determinants of handicap after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2004;35:715-720. (Pubitemid 38280847)
98. Reding MJ, Orto LA, Winter SW, et al. Antidepressant therapy after stroke: a double-blind trial. Arch Neurol. 1986;43:763-765. (Pubitemid 16034221)
99. Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 1996;27(7):1211-1214. (Pubitemid 26226957)
100. Chemerinski E, Robinson RG. The neuropsychiatry of stroke. Psychosomatics. 2000;41(1):5-14.
101. Wiart L, Petit H, Joseph PA, et al. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000;31:1829-1832. (Pubitemid 30620458)
102. Chemerinski E, Robinson RG, Arndt S, et al. The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study. J Nerv Ment Dis. 2001;189(7):421-425. (Pubitemid 32730204)
103. Grade C, Redford B, Chrostowski J, et al. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil. 1998;79(9):1047-1050. (Pubitemid 28419310)
104. Fruehwald S, Gatterbauer E, Rehak P, et al. Early fluoxetine treatment of post-stroke depression-a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol. 2003;250(3):347-351. (Pubitemid 36399276)
105. Murray V, von Arbin M, Bartfai A, et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry. 2005;66(6):708-716. (Pubitemid 40942416)
106. Choi-Kwon S, Han SW, Kwon SU, et al. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke. 2006;37(1):156-161. (Pubitemid 43732065)